Analgesic effects and assays of controlled-release tramadol and o-desmethyltramadol in cancer patients with pain

Current Pharmaceutical Biotechnology

Volumn 12, Issue 2, 2011, Pages 306-312

  Leppert, Wojciech ^a   Mikolajczak, Przemyslaw ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Analgesia; Cancer pain; Opioid; Tramadol; Treatment

Indexed keywords

DIHYDROCODEINE; O NORTRAMADOL; TRAMADOL;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; BRIEF PAIN INVENTORY; CANCER PAIN; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSE TITRATION; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 79551645175     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111794295738     Document Type: Article

References (30)

1. Grond, S.; Meuser, T. Weak opioids - an educational substitute for morphine? Curr. Opin. Anesthesiol., 1998, 11, 559-565.
2. Hennies, M. H.; Friderichs, E.; Schneider, J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung, 1988, 38, 877-880.
3. Raffa, R. B.; Friderichs, E.; Reimann, W.; Shank, R. P.; Codd, E. E.; Vaught, J. L. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an "atypical" opioid analgesic. J. Pharmacol. Exp. Ther., 1992, 260, 275-285.
4. Houmes, R. J. M.; Voets, M. A.; Verkaaik, A.; Erdmann, W.; Lachmann, B. Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regard to respiratory depression. Anesth. Analg., 1992, 74, 510-514.
5. Vickers, M.; O'Flaherty, D.; Szekely, S. M.; Read, M.; Yoshizumi, J. Tramadol: Pain relief by an opioid without depression of respiration. Anaesthesia, 1992, 47, 291-296.
6. Preston, K.L.; Jasinski, D.R.; Testa, M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend., 1991, 27, 7-17.
7. Husslein P.; Kubista, E.; Egarter, C. Obstetric analgesia with tramadol- results of a prospective randomised comparison with pethidine. Z. Geburtsh. Perinatol., 1987, 191, 234-237.
8. Kupers, R.; Callebaut, V.; Debois, V.; Camu, F.; Verborgh, C.; Coppejans, H.; Adriaensen, H. Efficacy and safety of oral tramadol and pentazocine for postoperative pain following prolapsed intervertebral disc repair. Acta Anaesth. Belg., 1995, 46, 31-37.
9. Leppert, W. Tramadol as an analgesic for mild to moderate cancer pain. Pharmacol. Rep., 2009, 61, 978-992.
10. Vlase, L.; Leucuta, S.E.; Imre, S. Determination of tramadol and O-desmethyltramadol in human plasma by high-performance liquid chromatography with mass spectrometry detection. Talanta, 2008, 75, 1104-1109.
11. Leppert, W.; Majkowicz, M. Ocena analgezji i objawow niepozadanych tramadolu I dihydrokodeiny o kontrolowanym uwalnianiu u chorych z bolem nowotworowym - na podstawie zmodyfikowanej skali ESAS (Polish). Wspolcz. Onkol., 2008, 12, 246-254.
12. Wilder-Smith, C.H.; Hufschmid, E.; Thormann, W. The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor matabolizers. Br. J. Clin. Pharmacol., 1998, 45, 575-581.
13. Mikus, G.; Weiss, J. Influence of CYP2D6 genetics on opioid kinetics, metabolism and response. Curr. Pharmacogenom., 2005, 3, 43-52.
14. Lehmann, K.A.; Kratzenberg, U.; Schroeder-Bark, B.; Horrichs- Haermeyer, G. Postoperative patient-controlled analgesia with tramadol: analgesic efficacy and minimum effective concentrations. Clin. J. Pain, 1990, 6, 212-220.
15. Mikus, G.; Somogyi, A.A.; Bochner, F.; Chen, Z.R. Polymorphic metabolism of opioid narcotic drugs: possible clinical implications. Ann. Acad. Med. Singapore, 1991, 20, 9-12.
16. Stamer, U.M.; Lehnen, K.; Höthker, F.; Bayerer, B.; Wolf, S.; Hoeft, A.; Stuber, F. Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain, 2003, 105, 231-238.
17. Stamer, U.; Musshoff, F.; Kobilay, M.; Madea, B.; Hoeft, A.; Stuber, F. Concentrations of tramadol and o-desmethyltramadol enantiomers in different CY2D6 genotypes. Clin. Pharmacol. Ther., 2007, 82, 41-47.
18. García-Quetglas, E.; Azanza, J. R.; Sádaba, B.; Muñoz, M. J.; Gil, I.; Campanero, M. A. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype. Pharmacol. Res., 2007, 55, 122-130.
19. Kirchheiner, J.; Keulen, J-T.H.A.; Bauer, S.; Roots, I.; Brockmöller, J. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol. J. Clin. Psychopharmacol., 2008, 28, 78-83.
20. Stamer, U.; Stuber, F.; Muders, T.; Musshoff, F. Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication. Anesth. Analg., 2008, 107, 926-929.
21. Lintz, W.; Erlacin, S.; Frankus, E.; Uragg, H. Biotransformation of tramadol in man and animal. Arznneimittelforschung, 1981, 31, 1932-1943.
22. Paar, W.D.; Frankus, P.; Dengler, H.J. The metabolism of tramadol by human liver microsomes. Clin. Invest., 1992, 70, 708-710.
23. Paar, W.D.; Poche, S.; Gerloff, J.; Dengler, H.J. Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol. Eur. J. Clin. Pharmacol., 1997, 53, 235-239.
24. Leppert, W. Dihydrocodeine as an analgesic for the treatment of moderate to severe chronic pain. Curr. Drug Metab., 2010, 11, 494-506.
25. Wilder - Smith, C.H.; Bettiga, A. The analgesic tramadol has minimal effect on gastrointestinal motor function. Br. J. Clin. Pharmacol., 1997, 43, 71-75.
26. Leppert, W.; Luczak, J. The role of tramadol in cancer pain treatment- a review. Support. Care Cancer, 2005, 13, 5-17.
27. Ingelman-Sundberg, M. Genetic polymorphism of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenom. J., 2005, 5, 6-13.
28. Sindrup, S.H.; Madsen, C.; Brøsen, K.; Jensen, T.S. The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolite levels. Clin. Pharmacol. Ther., 1999, 66, 636-641.
29. Duggan, A.K. The cost of constipation in morphine patients and the economic possibilities with tramadol. Br. J. Med. Econom., 1995, 9, 21-29.
30. Leppert, W.; Luczak, J.; Oliver, D. Tramadol and cancer pain. Eur. J. Palliat. Care, 2002, 9, 49-51.